Klaus Stöhr, former head of the World Health Organization's (WHO) Global Influenza Programme, stepped down this month to take a position with Novartis Vaccines and Diagnostics, leading the company's development of seasonal and H5N1 influenza vaccines. At the WHO, Stöhr was known as a visible advocate of developing vaccines against the H5N1 strain of influenza and worked to assemble national policies for surveillance and preparedness against a flu pandemic. Because of Stöhr's efforts, "the imperative of having to develop a better influenza vaccine for seasonal flu and a vaccine for pandemic flu is on the front burner," Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told The Scientist. "He got the ball rolling," Fauci said. A spokesperson at the WHO said there has not been a direct replacement for Stöhr's position. Albert Osterhaus, virology professor at Erasmus Medical Center in...
The Scientistvaccine shortageThe Scientistflu cell cultureleftJohn OxfordThe Scientistkgrens@the-scientist.comhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Stohr+K%22%5BAuthor%5Dhttp://www.who.int/csr/disease/influenza/mission/enhttp://www.novartis-vaccines.comThe Scientisthttp://www.the-scientist.com/article/display/22476/http://www3.niaid.nih.gov/about/directorshttp://www.virology.nlThe Scientisthttp://www.the-scientist.com/article/display/15317/The Scientisthttp://www.the-scientist.com/news/display/23259/The Scientisthttp://www.the-scientist.com/news/display/23340/http://www.icms.qmul.ac.uk/centres/infectiousdisease/staff/index.html
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!